TD Cowen analyst Tyler Van Buren downgraded Soleno Therapeutics Inc. (NASDAQ: SLNO) from Buy to Hold with a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Downgrades